Skip to main content

Advertisement

SpringerLink
Log in

Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Different stimuli, including pharmacological stimuli, induce different neuroanatomical profiles of c-fos expression. Can these profiles be used in classifying psychoactive drugs and predicting therapeutic utility?

Objective

To test the validity of c-fos expression profiling to aid therapeutic classification.

Methods

Anxiolytics, antidepressants, antipsychotics and psychostimulants were compared. (i) A meta-analysis was performed and profiles compiled from literature reports of changes in c-fos expression in rat brain regions, measured by in situ hybridisation histochemistry or immunohistochemistry, after acute injection of psychoactive drugs. (ii) Male rat brains were profiled for changes in c-fos mRNA expression induced by acute injection of psychoactive drugs.

Results

(i) The meta-analysis showed that anxiolytics activate few (mostly stress-related) brain regions; antidepressants activate more regions, including the central amygdaloid nucleus; antipsychotics activate more regions still, including the nucleus accumbens and striatal areas; and psychostimulants activate the greatest number of all, including the most cortical regions (especially the piriform cortex). Profiles also varied within drug classes. (ii) Our experimental profiles confirmed and extended meta-analysis profiles, showing more downregulation. (iii) Sites activated by mirtazapine (an antidepressant not previously profiled) matched those of the antidepressant imipramine.

Conclusions

(i) Differences between drug classes support their classification by means of c-fos profiling. Differences within classes may reflect mechanistic variations. (ii) Greater downregulation in our experiments might be because of inclusion of low, clinically relevant, drug doses and fuller coverage of brain regions. (iii) The agreement between mirtazapine and imipramine increases our confidence in the validity of c-fos expression profiling to aid drug classification and predict therapeutic utility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alheid GF, Heimer L (1996) Theories of basal forebrain organization and the 'emotional motor system'. Prog Brain Res 107:461–484

    CAS  PubMed  Google Scholar 

  • Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410

    Article  CAS  PubMed  Google Scholar 

  • Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE (1998) Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18:10579–10593

    CAS  PubMed  Google Scholar 

  • Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 383–435

  • Beck CHM (1995) Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. J Psychiatry Neurosci 20:25–32

    CAS  PubMed  Google Scholar 

  • Beckmann AM, Wilce PA (1997) EGR transcription factors in the nervous system. Neurochem Int 31:477–510

    Article  CAS  PubMed  Google Scholar 

  • Bennett HJ, Semba K (1998) Immunohistochemical localization of caffeine-induced c-fos protein expression in the rat brain. J Comp Neurol 401:89–108

    Article  CAS  PubMed  Google Scholar 

  • Bonaventure P, Guo H, Tian B, Liu X, Bittner A, Roland B, Salunga R, Ma X-J, Kamme F, Meurers B, Bakker M, Jurzak M, Leysen JE, Erlander MG (2002) Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res 943:38–47

    Article  CAS  PubMed  Google Scholar 

  • Bujas-Bobanovic M, Robertson HA, Dursun SM (2000) Effects of nitric oxide synthase inhibitor N(G)-nitro-l-arginine methyl ester on phencyclidine-induced effects in rats. Eur J Pharmacol 409:57–65

    Article  CAS  PubMed  Google Scholar 

  • Carta AR, Gerfen CR (1999) Lack of a role for the D3 receptor in clozapine induction of c-fos demonstrated in D3 dopamine receptor-deficient mice. Neuroscience 90:1021–1029

    Article  CAS  PubMed  Google Scholar 

  • Castner SA, Becker JB (1996) Sex differences in the effect of amphetamine on immediate early gene expression in the rat dorsal striatum. Brain Res 712:245–257

    Article  CAS  PubMed  Google Scholar 

  • Cenci MA, Kalen P, Mandel RJ, Wictorin K, Bjorklund A (1992) Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience 46:943–957

    Article  CAS  PubMed  Google Scholar 

  • Chaudhuri A (1997) Neural activity mapping with inducible transcription factors Neuroreport 8:iii–vii

    CAS  Google Scholar 

  • Cochran SM, McKerchar CE, Morris BJ, Pratt JA (2002) Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol. Neuropharmacology 43:394–407

    Article  CAS  PubMed  Google Scholar 

  • Cohen BM, Wan W (1996) The thalamus as a site of action of antipsychotic drugs. Am J Psychiatry 153:104–106

    CAS  PubMed  Google Scholar 

  • Cookson J, Taylor D, Katonia C (2002) Use of drugs in psychiatry, 5th edn. Gaskell, Royal College of Psychiatrists, London

  • Davis M, Shi C (1999) The central extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann NY Acad Sci 877:281–291

    CAS  PubMed  Google Scholar 

  • Dawe GS, Huff KD, Vandergriff JL, Sharp TL, O'Neill MJ, Rasmussen K (2001) Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-fos immunoreactivity. Biol Psychiatry 50:510–520

    Article  CAS  PubMed  Google Scholar 

  • Day HE, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ Jr, Akil H (2001) Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 21:732–740

    CAS  PubMed  Google Scholar 

  • De Boer T, Nefkens F, Van Helvoirt A (1994) The alpha2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 253: R5–R6

    PubMed  Google Scholar 

  • Deutsch AY, Duman RS (1996) The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience 70:377–389

    Article  PubMed  Google Scholar 

  • Deutsch AY, Ongur D, Duman RS (1995) Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action. Neuroscience 66:337–346

    Article  CAS  PubMed  Google Scholar 

  • Dezhi M, Liang W, Zhang G, Xiru W (1999) The relationship between the c-jun mRNA expression and apoptosis of neurons in rat brain following perinatal ischemic-hypoxia. Chin Med J (Engl) 112:40–43

    Google Scholar 

  • Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261–265

    CAS  PubMed  Google Scholar 

  • Dragunow M, Faull RL (1990) MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett 113:144–150

    Article  CAS  PubMed  Google Scholar 

  • Duncan GE, Knapp DJ, Johnson KB, Breese GR (1996) Functional classification of antidepressants based on antagonism of swim-stress-induced fos-like immunoreactivity. J Pharmacol Exp Ther 277:1076–1089

    CAS  PubMed  Google Scholar 

  • Duncan GE, Moym SS, Knapp DJ, Mueller RA, Breese GR (1998) Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787:181–190

    CAS  PubMed  Google Scholar 

  • Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV (1998) Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 241:95–98

    Article  CAS  Google Scholar 

  • Fink-Jensen A, Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci Lett 182:115–118

    CAS  PubMed  Google Scholar 

  • Fink-Jensen A, Ludvigsen TS, Korsgaard N (1995) The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5HT2 receptor blockade to haloperidol. Neurosci Lett 194: 77–80

    Article  CAS  PubMed  Google Scholar 

  • Frodl T, Meisenzahl E, Zetzsche T, Bottlender R, Born C, Groll C, Jager M, Leinsinger G, Hahn K, Moller H-J (2002) Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 51:708–714

    Article  PubMed  Google Scholar 

  • Fujimura M, Hashimoto K, Yamagami K (2000a) Effects of antipsychotic drugs on neurotoxicity: expression of Fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine. Eur J Pharmacol 398:1–10

    Article  CAS  PubMed  Google Scholar 

  • Fujimura M, Hashimoto K, Yamagami K (2000b) The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. Life Sci 67:2865–2872

    Article  CAS  PubMed  Google Scholar 

  • Gao XM, Hashimoto T, Tamminga CA (1998) Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29:14–28

    Article  CAS  PubMed  Google Scholar 

  • Gass P, Herdegen T, Bravo R, Kiessling M (1993) Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-d-aspartate receptor antagonist MK-801. Neuroscience 53:749–758

    Article  CAS  PubMed  Google Scholar 

  • Guitart X, Farre AJ (1998) The effect of E-5842, a sigma receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain. Eur J Pharmacol 363:127–130

    Article  CAS  PubMed  Google Scholar 

  • Guo N, Klitenick MA, Tham CS, Fibiger HC (1995) Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65:747–756

    Article  CAS  PubMed  Google Scholar 

  • Habara T, Hamamura T, Miki M, Ohashi K, Kuroda S (2001) M100,907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain. Eur J Pharmacol 417:189–194

    Article  CAS  PubMed  Google Scholar 

  • Hamamura T, Ichimaru Y, Fibiger HC (1997) Amphetamine sensitization enhances regional c-fos expression produced by conditioned fear. Neuroscience 76:1097–1103

    Article  CAS  PubMed  Google Scholar 

  • Herdegen T, Leah JD (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Rev 28:370–490

    CAS  PubMed  Google Scholar 

  • Herrera DG, Robertson HA (1996) Activation of c-fos in the brain. Progr Neurobiol 50:83–107

    Article  CAS  Google Scholar 

  • Hess US, Lynch G, Gall CM (1995) Regional patterns of c-fos mRNA expression in rat hippocampus following exploration of a novel environment versus performance of a well-learned discrimination. J Neurosci 15:7796–7809

    CAS  PubMed  Google Scholar 

  • Hinks GL, Brown P, Field M, Poat JA, Hughes J (1996) The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. Eur J Pharmacol 312:153–161

    Article  CAS  PubMed  Google Scholar 

  • Hiroi N, Graybiel AM (1996) Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 374:70–83

    Article  CAS  PubMed  Google Scholar 

  • Hoffman GE, Lyo D (2002) Anatomical markers of activity in neuroendocrine systems. Are we all 'Fos-ed' out? J Neuroendocrinol 14:259–268

    Article  CAS  PubMed  Google Scholar 

  • Hughes P, Dragunow M, Beilharz E, Lawlor P, Gluckman P (1993) MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones. Neuroreport 4:183–186

    CAS  PubMed  Google Scholar 

  • Hurley MJ, Stubbs CM, Jenner P, Marsden CD (1996) Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics. Eur J Pharmacol 318:283–293

    CAS  PubMed  Google Scholar 

  • Hussain N, Flumerfelt BA, Rajakumar N (2001) Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience 102:391–399

    Article  CAS  PubMed  Google Scholar 

  • Imaki T, Wang XQ, Shibasaki T, Harada S, Chikada N, Takahashi C, Naruse M, Demura H (1995) Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol Brain Res 32:261–270

    Article  CAS  PubMed  Google Scholar 

  • Ishibashi T, Tagashira R, Nakamura M, Noguchi H, Ohno Y (1999) Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain. Pharmacol Biochem Behav 63:535–541

    Article  CAS  PubMed  Google Scholar 

  • Jaber M, Cador M, Dumartin B, Normand E, Stinus L, Bloch B (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65:1041–1050

    Article  CAS  PubMed  Google Scholar 

  • Javed A, Van De Kar LD, Gray TS (1997) p-Chlorophenylalanine and fluoxetine inhibit d-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions. Brain Res 774:94–105

    Article  CAS  PubMed  Google Scholar 

  • Johansson B, Lindstrom K, Fredholm BB (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837–849

    Article  CAS  PubMed  Google Scholar 

  • Jones MW, Errington ML, French PJ, Fine A, Bliss TVP, Garel S, Charnay P, Bozon B, Laroche S, Davis S (2001) A requirement for the immediate early gene zif268 in the expression of late LTP and long-term memories. Nat Neurosci 4:289–296

    CAS  PubMed  Google Scholar 

  • Kaczmarek L, Robertson HA (2002) Immediate early genes and inducible transcription factors in mapping of the central nervous system function and dysfunction. In: Bjorklund A, Hokfelt T (eds) Handbook of chemical neuroanatomy, vol 19. Elsevier, Amsterdam

  • Kawashima N, Nakamura A, Okuyama S, Chaki S, Tomisawa K (1999) Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain. Gen Pharmacol 32:637–646

    Article  CAS  PubMed  Google Scholar 

  • Komisaruk BR, Rosenblatt JS, Barona ML, Chinapen S, Nissanov J, O'Brannon RT, Johnson BM, Del Cerro MCR (2000) Combined c-fos and C-14-2-deoxyglucose method to differentiate site-specific excitation from disinhibition: analysis of maternal behaviour in the rat. Brain Res 859:262–272

    Article  CAS  PubMed  Google Scholar 

  • Kovacs KJ, Csejtei M, Laszlovszky I (2001) Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D3 receptor selective RGH-1756. Neuropharmacology 40:383–393

    Article  CAS  PubMed  Google Scholar 

  • Labiner DM, Butler LS, Cao Z, Hosford DA, Shin C, McNamara JO (1993) Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J Neurosci 13:744–751

    CAS  PubMed  Google Scholar 

  • Lee S, Rivier C, Torres G (1994) Induction of c-fos and CRF mRNA by MK-801 in the parvocellular paraventricular nucleus of the rat hypothalamus. Mol Brain Res 24:192–198

    Article  CAS  PubMed  Google Scholar 

  • Leslie RA, James MF (2000) Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21:314–318

    Article  CAS  PubMed  Google Scholar 

  • Lillrank SM, Lipska BK, Bachus SE, Wood GK, Weinberger DR (1996) Amphetamine-induced c-fos mRNA expression is altered in rats with neonatal ventral hippocampal damage. Synapse 23:292–301

    Article  CAS  PubMed  Google Scholar 

  • Lino-de-Oliveira C, Sales AJ, Del Bel EA, Silveira MC, Guimaraes FS (2001) Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression. Brain Res Bull 55:747–754

    Article  CAS  PubMed  Google Scholar 

  • Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, Jenkins NA, Lanahan AA, Worley PF (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14:433–445

    CAS  PubMed  Google Scholar 

  • MacGibbon GA, Lawlor PA, Bravo R, Dragunow M (1994) Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 23:21–32

    CAS  PubMed  Google Scholar 

  • Mach RH, Nader MA, Ehrenkaufer RLE, Line SW, Smith CR, Gage D, Morton TE (1997) Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol Biochem Behav 57:477–486

    CAS  PubMed  Google Scholar 

  • Mao L, Wang JQ (2002) Activation of metabotropic glutamate receptor mediates upregulation of transcription factor mRNA expression in rat striatum induced by acute administration of amphetamine. Brain Res 924:167–175

    Article  CAS  PubMed  Google Scholar 

  • Mathieu-Kia A-M, Pages C, Besson M-J (1998) Inducibility of c-fos protein in visuo-motor system and limbic structures after acute and repeated administration of nicotine in the rat. Synapse 29:343–354

    Article  CAS  PubMed  Google Scholar 

  • Martin P, Carlsson ML, Hjorth S (1998) Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport 9:2985–2988

    CAS  PubMed  Google Scholar 

  • Menza M, Marin H, Opper RS (2003) Residual symptoms in depression: can treatment be symptom specific? J Clin Psychiatry 64:516–523

    PubMed  Google Scholar 

  • Merchant KM, Hanson GR, Dorsa DM (1994) Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J Pharmacol Exp Ther 269:806–812

    CAS  PubMed  Google Scholar 

  • Miller DD, Andreasen NC, O'Leary DS, Watkins GL, Ponto LLB, Hichwa RD (2001) Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry 49:704–715

    Article  CAS  PubMed  Google Scholar 

  • Miyamoto S, Duncan GE, Mailman RB, Lieberman JA (2000) Developing novel antipsychotic drugs: strategies and goals. Curr Opin Investig Drugs 2:25–39

    CAS  Google Scholar 

  • Morinobu S, Strausbaugh H, Terwilliger R, Duman RS (1997) Regulation of c-fos and NGFI-A by antidepressant treatments. Synapse 25:313–320

    Article  CAS  PubMed  Google Scholar 

  • Morelli M, Pinna A (1999) Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala. Ann NY Acad Sci 877:703–706

    CAS  PubMed  Google Scholar 

  • Morelli M, Pinna A, Ruiu S, Del Zompo M (1999) Induction of Fos-like immunoreactivity in the central extended amygdala by antidepressant drugs. Synapse 31:1–4

    Article  CAS  PubMed  Google Scholar 

  • Nakki R, Sharp FR, Sagar SM, Honkaniemi J (1996) Effects of phencyclidine on immediate early gene expression in the brain. J Neurosci Res 45:13–27

    Article  CAS  Google Scholar 

  • Ohashi K, Hamamura T, Fujiwara Y, Suzuki H, Kuroda S (2000) Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors. Neuropsychopharmacology 23:162–169

    Google Scholar 

  • Palacios G, Muro MA, Paz Marin A (1996) Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens. Brain Res 742:141–148

    Article  PubMed  Google Scholar 

  • Palmer LC, Hess US, Larson J, Rogers GA, Gall CM, Lynch G (1997) Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum. Mol Brain Res 46:127–135

    Article  CAS  PubMed  Google Scholar 

  • Panegyres PK, Hughes J (1997) Activation of c-fos mRNA in the brain by the kappa-opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine. Eur J Pharmacol 328:31–36

    Article  CAS  PubMed  Google Scholar 

  • Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, compact 3rd edn. Academic Press, San Diego

  • Pei Q, Lewis L, Sprakes ME, Jones EJ, Grahame-Smith DG, Zetterstrom TSC (2000) Serotonic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites. Neuropharmacology 39:463–470

    Article  CAS  PubMed  Google Scholar 

  • Pinna A, Wardas J, Cozzolino A, Morelli M (1999) Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 20:44–51

    Article  CAS  PubMed  Google Scholar 

  • Preece M, Mukherjee B, Huang CL-H, Hall LD, Leslie RA, James MF (2001) Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat. Brain Res 916:107–114

    Article  CAS  PubMed  Google Scholar 

  • Robertson GS, Fibiger HC (1996) Effects of olanzapine on regional c-fos expression in rat forebrain. Neuropsychopharmacology 14:105–110

    Article  CAS  PubMed  Google Scholar 

  • Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058–1066

    CAS  PubMed  Google Scholar 

  • Ruigt GSF, van Proosdij JN, van Wezenbeek LACM (1989) A large-scale, high-resolution, automated system for rat sleep staging. I. Methodology and technical aspects. II. Validation and application. Electroencephalogr Clin Neurophysiol 73:52–71

    Article  CAS  PubMed  Google Scholar 

  • Ruigt GSF, Engelen S, Gerrits A, Verbon F (1993) Computer-based prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep. Neuropsychobiology 28:138–153

    CAS  PubMed  Google Scholar 

  • Ruskin DN, Marshall JF (1994) Amphetamine- and cocaine-induced Fos in the rat striatum depends on D2 receptor activation. Synapse 18:233–240

    CAS  PubMed  Google Scholar 

  • Salminen O, Lahtinen S, Ahtee L (1996) Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. Pharmacol Biochem Behav 54:241–248

    Article  CAS  PubMed  Google Scholar 

  • Sato D, Umino A, Kaneda K, Takigawa M, Nishikawa T (1997) Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain. Neurosci Lett 239:21–24

    Article  CAS  PubMed  Google Scholar 

  • Schilstrom B, de Villiers S, Malmerfelt A, Svensson TH, Nomikos GG (2000) Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex in the rat: role of nicotinic and NMDA receptors in the ventral tegmental area. Synapse 36:314–321

    Article  PubMed  Google Scholar 

  • Sebens JB, Koch T, Korf J (1996) Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions. Eur J Pharmacol 315:269–275

    Article  CAS  PubMed  Google Scholar 

  • Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27–38

    PubMed  Google Scholar 

  • Semba J, Sakai M, Miyoshi R, Mataga N, Fukamauchi F, Kito S (1996) Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study. Neurochem Int 29:435–442

    Article  CAS  PubMed  Google Scholar 

  • Semba J, Sakai MW, Suhara T, Akanuma N (1999) Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization. Neurochem Int 34:269–277

    Article  CAS  PubMed  Google Scholar 

  • Semba J, Tanaka N, Wakuta M, Suhara T (2001) Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain. Synapse 40:11–18

    Article  CAS  PubMed  Google Scholar 

  • Seppa T, Salminen O, Moed M, Ahtee L (2001) Induction of Fos-immunostaining by nicotine and nicotinic receptor antagonists in rat brain. Neuropharmacology 41:486–495

    Article  CAS  PubMed  Google Scholar 

  • Sharp FR, Sagar SM, Swanson RA (1993) Metabolic mapping with cellular resolution: c-fos vs 2-deoxyglucose. Crit Rev Neurobiol 7:205–228

    CAS  PubMed  Google Scholar 

  • Sharp JW (1997) Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression. Brain Res 758:51–58

    CAS  PubMed  Google Scholar 

  • Sheng M, Greenberg ME (1990) The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4:477–485

    CAS  PubMed  Google Scholar 

  • Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS (2002) Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 51:693–707

    Article  PubMed  Google Scholar 

  • Singewald N, Sharp T (2000) Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98:759–770

    Article  CAS  PubMed  Google Scholar 

  • Singewald N, Salchner P, Sharp T (2003) Induction of c-fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275–283

    Article  CAS  PubMed  Google Scholar 

  • Steiner H, Gerfen CR (1993) Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13:5066–5081

    CAS  PubMed  Google Scholar 

  • Sun YJ, Suzuki M, Kurachi T, Murata M, Kurachi M (1998) Expression of Fos protein in the limbic regions of the rat following haloperidol decanoate. Brain Res 791:125–136

    CAS  PubMed  Google Scholar 

  • Suzuki M, Sun YJ, Murata M, Kurachi M (1998) Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain. Psychiatry Clin Neurosci 52:353–359

    Article  CAS  PubMed  Google Scholar 

  • Torres G (1994) Acute administration of alcohol blocks cocaine-induced striatal c-fos immunoreactivity protein in the rat. Synapse 18:161–167

    CAS  PubMed  Google Scholar 

  • Torres G, Horowitz JM, Laflamme N, Rivest S (1998) Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain. Neuroscience 87:463–477

    Article  CAS  PubMed  Google Scholar 

  • Turgeon SM, Case LC (2001) The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat. Brain Res 888:302–305

    Article  CAS  PubMed  Google Scholar 

  • Turgeon SM, Roche JK (1999) The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal c-Fos expression in the rat. Neuroscience 91:1265–1275

    CAS  PubMed  Google Scholar 

  • Umino A, Nishikawa T, Takahashi K (1995) Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem Int 26:85–90

    Article  CAS  PubMed  Google Scholar 

  • Uslaner J, Badiani A, Norton CS, Day HE, Watson SJ, Akil H, Robinson TE (2001) Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13:1977–1983

    Article  CAS  PubMed  Google Scholar 

  • Vahid-Ansari F, Robertson GS (1996) 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. Eur J Neurosci 8:2605–2611

    CAS  PubMed  Google Scholar 

  • VanderSpek SC, Nobrega J, Brownlee BA, Seeman P, Kapur S (2002) Animal studies of antipsychotics use doses which are not representative of the clinical condition—potential implications and suggested solutions. Biol Psychiatry 51:121S

    Google Scholar 

  • Volkow ND, Wang G-J, Fowler JS, Gatley SJ, Ding Y-S, Logan J, Dewey SL, Hitzeman R, Lieberman J (1996) Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA 93:10388–10392

    Article  CAS  PubMed  Google Scholar 

  • Wan W, Ennulat DJ, Cohen BM (1995) Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res 688:95–104

    Article  CAS  PubMed  Google Scholar 

  • Wang JQ, Smith AJ, McGinty JF (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68:83–95

    CAS  PubMed  Google Scholar 

  • Wedzony K, Czyrak A (1996) Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior cingulate cortex. J Physiol Pharmacol 47:525–533

    CAS  PubMed  Google Scholar 

  • Werme M, Ringholm A, Olson L, Brene S (2000) Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res 863:112–119

    Article  CAS  PubMed  Google Scholar 

  • Wintrip N, Nance DM, Wilkinson M (1998) Sexually dimorphic MK801-induced c-fos in the rat hypothalamic paraventricular nucleus. Neurosci Lett 242:151–154

    Article  CAS  PubMed  Google Scholar 

  • Wirtshafter D, Asin KE (1999) Haloperidol induces c-fos expression in the globus pallidus and substantia nigra of cynomolgus monkeys. Brain Res 835:154–161

    Article  CAS  PubMed  Google Scholar 

  • Wisden W, Morris BJ (eds) (1994) In situ hybridization protocols for the brain. Academic Press, London

  • Wittliff JL, Erlander MG (2002) Laser capture microdissection and its applications in genomics and proteomics. Methods Enzymol 356:12–25

    CAS  PubMed  Google Scholar 

  • Wrynne AS, Sebens JB, Koch T, Leonard BE, Korf J (2000) Prolonged c-jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset. Mol Brain Res 76:7–17

    Article  PubMed  Google Scholar 

  • Young CD, Meltzer HY, Deutch AY (1998) Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite. Neuropsychopharmacology 19:99–103

    Google Scholar 

  • Zangenehpour S, Chaudhuri A (2002) Differential induction and decay curves of c-fos and zif268 revealed through dual activity maps. Mol Brain Res 109:221–225

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Organon Laboratories Ltd., Newhouse, Lanarkshire , ML1 5SH, Scotland, UK

    B. E. H. Sumner, L. A. Cruise, D. A. Slattery, D. R. Hill, M. Shahid & B. Henry

  2. Psychopharmacology Unit, School of Medical Sciences, University of Bristol, University Walk, Bristol, BS8 1TD, UK

    D. A. Slattery

Authors
  1. B. E. H. Sumner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. A. Cruise
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. A. Slattery
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. R. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Shahid
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. E. H. Sumner.

Appendix

Appendix

References selected for the c-fos meta-analysis

  • Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE (1998) Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18:10579–10593

  • Beck CHM (1995) Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. J Psychiatry Neurosci 20:25–32

  • Bennett HJ, Semba K (1998) Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain. J Comp Neurol 401:89–108

  • Bujas-Bobanovic M, Robertson HA, Dursun SM (2000) Effects of nitric oxide synthase inhibitor N(G)-nitro-l-arginine methyl ester on phencyclidine-induced effects in rats. Eur J Pharmacol 409:57–65

  • Carta AR, Gerfen CR (1999) Lack of a role for the D3 receptor in clozapine induction of c-fos demonstrated in D3 dopamine receptor-deficient mice. Neuroscience 90:1021–1029

  • Castner SA, Becker JB (1996) Sex differences in the effect of amphetamine on immediate early gene expression in the rat dorsal striatum. Brain Res 712:245–257

  • Cenci MA, Kalen P, Mandel RJ, Wictorin K, Bjorklund A (1992) Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience 46:943–957

  • Cochran SM, McKerchar CE, Morris BJ, Pratt JA (2002) Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol. Neuropharmacology 43:394–407

  • Cohen BM, Wan W (1996) The thalamus as a site of action of antipsychotic drugs. Am J Psychiatry 153:104–106

  • Dawe GS, Huff KD, Vandergriff JL, Sharp TL, O'Neill MJ, Rasmussen K (2001) Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-fos immunoreactivity. Biol Psychiatry 50:510–520

  • Day HE, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ Jr, Akil H (2001) Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 21:732–740

  • Deutsch AY, Ongur D, Duman RS (1995) Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action. Neuroscience 66:337–346

  • Dragunow M, Faull RL (1990) MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett 113:144–150

  • Duncan GE, Moym SS, Knapp DJ, Mueller RA, Breese GR (1998) Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787:181–190

  • Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV (1998) Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 241:95–98

  • Fink-Jensen A, Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci Lett 182:115–118

  • Fink-Jensen A, Ludvigsen TS, Korsgaard N (1995) The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5HT2 receptor blockade to haloperidol. Neurosci Lett 194:77–80

  • Fujimura M, Hashimoto K, Yamagami K (2000b) The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. Life Sci 67:2865–2872

  • Gao XM, Hashimoto T, Tamminga CA (1998) Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29:14–28

  • Gass P, Herdegen T, Bravo R, Kiessling M (1993) Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 53:749–758

  • Guitart X, Farre AJ (1998) The effect of E-5842, a sigma receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain. Eur J Pharmacol 363:127–130

  • Guo N, Klitenick MA, Tham CS, Fibiger HC (1995) Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65:747–756

  • Habara T, Hamamura T, Miki M, Ohashi K, Kuroda S (2001) M100,907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain. Eur J Pharmacol 417:189–94

  • Hinks GL, Brown P, Field M, Poat JA, Hughes J (1996) The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. Eur J Pharmacol 312:153–161

  • Hiroi N, Graybiel AM (1996) Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 374:70–83

  • Hughes P, Dragunow M, Beilharz E, Lawlor P, Gluckman P (1993) MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones. Neuroreport 4:183–186

  • Hurley MJ, Stubbs CM, Jenner P, Marsden CD (1996) Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics. Eur J Pharmacol 318:283–293

  • Hussain N, Flumerfelt BA, Rajakumar N (2001) Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience 102:391–399

  • Imaki T, Wang XQ, Shibasaki T, Harada S, Chikada N, Takahashi C, Naruse M, Demura H (1995) Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol Brain Res 32:261–270

  • Ishibashi T, Tagashira R, Nakamura M, Noguchi H, Ohno Y (1999) Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain. Pharmacol Biochem Behav 63:535–541

  • Jaber M, Cador M, Dumartin B, Normand E, Stinus L, Bloch B (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65:1041–1050

  • Javed A, Van De Kar LD, Gray TS (1997) p-Chlorophenylalanine and fluoxetine inhibit d-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions. Brain Res 774:94–105

  • Johansson B, Lindstrom K, Fredholm BB (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837–849

  • Kawashima N, Nakamura A, Okuyama S, Chaki S, Tomisawa K (1999) Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain. Gen Pharmacol 32:637–646

  • Kovacs KJ, Csejtei M, Laszlovszky I (2001) Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D3 receptor selective RGH-1756. Neuropharmacology 40:383–393

  • Lee S, Rivier C, Torres G (1994) Induction of c-fos and CRF mRNA by MK-801 in the parvocellular paraventricular nucleus of the rat hypothalamus. Mol Brain Res 24:192–198

  • Lillrank SM, Lipska BK, Bachus SE, Wood GK, Weinberger DR (1996) Amphetamine-induced c-fos mRNA expression is altered in rats with neonatal ventral hippocampal damage. Synapse 23:292–301

  • Lino-de-Oliveira C, Sales AJ, Del Bel EA, Silveira MC, Guimaraes FS (2001) Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression. Brain Res Bull 55:747–754

  • MacGibbon GA, Lawlor PA, Bravo R, Dragunow M (1994) Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 23:21–32

  • Mao L, Wang JQ (2002) Activation of metabotropic glutamate receptor mediates upregulation of transcription factor mRNA expression in rat striatum induced by acute administration of amphetamine. Brain Res 924:167–175

  • Mathieu-Kia A-M, Pages C, Besson M-J (1998) Inducibility of c-fos protein in visuo-motor system and limbic structures after acute and repeated administration of nicotine in the rat. Synapse 29:343–354

  • Merchant KM, Hanson GR, Dorsa DM (1994) Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J Pharmacol Exp Ther 269:806–812

  • Morelli M, Pinna A (1999) Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala. Ann. N. Y. Acad. Sci. 877:703–706

  • Morelli M, Pinna A, Ruiu S, Del Zompo M (1999) Induction of Fos-like immunoreactivity in the central extended amygdala by antidepressant drugs. Synapse 31:1–4

  • Nakki R, Sharp FR, Sagar SM, Honkaniemi J (1996) Effects of phencyclidine on immediate early gene expression in the brain. J Neuroscience Res 45:13–27

  • Ohashi K, Hamamura T, Fujiwara Y, Suzuki H, Kuroda S (2000) Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors. Neuropsychopharmacology 23:162–169

  • Palacios G, Muro MA, Paz Marin A (1996) Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens. Brain Res 742:141–148

  • Palmer LC, Hess US, Larson J, Rogers GA, Gall CM, Lynch G (1997) Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum. Mol Brain Res 46:127–135

  • Panegyres PK, Hughes J (1997) Activation of c-fos mRNA in the brain by the kappa-opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine. Eur J Pharmacol 328:31–36

  • Pinna A, Wardas J, Cozzolino A, Morelli M (1999) Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 20:44–51

  • Robertson GS, Fibiger HC (1996) Effects of olanzapine on regional c-fos expression in rat forebrain. Neuropsychopharmacology 14:105–110

  • Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058–1066

  • Ruskin DN, Marshall JF (1994) Amphetamine- and cocaine-induced Fos in the rat striatum depends on D2 receptor activation. Synapse 18:233–240

  • Salminen O, Lahtinen S, Ahtee L (1996) Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. Pharmacol Biochem Behav 54:241–248

  • Sato D, Umino A, Kaneda K, Takigawa M, Nishikawa T (1997) Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain. Neurosci Lett 239:21–24

  • Schilstrom B, de Villiers S, Malmerfelt A, Svensson TH, Nomikos GG (2000) Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex in the rat: role of nicotinic and NMDA receptors in the ventral tegmental area. Synapse 36:314–321

  • Sebens JB, Koch T, Korf J (1996) Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions. Eur J Pharmacol 315:269–275

  • Semba J, Sakai M, Miyoshi R, Mataga N, Fukamauchi F, Kito S (1996) Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study. Neurochem Int 29:435–442

  • Semba J, Sakai MW, Suhara T, Akanuma N (1999) Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization. Neurochem Int 34:269–277

  • Semba J, Tanaka N, Wakuta M, Suhara T (2001) Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain. Synapse 40:11–18

  • Seppa T, Salminen O, Moed M, Ahtee L (2001) Induction of Fos-immunostaining by nicotine and nicotinic receptor antagonists in rat brain. Neuropharmacology 41:486–495

  • Sharp JW (1997) Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression. Brain Res 758:51–58

  • Singewald N, Sharp T (2000) Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98:759–770

  • Singewald N, Salchner P, Sharp T (2003) Induction of c-fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275–283

  • Steiner H, Gerfen CR (1993) Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13:5066–5081

  • Sun YJ, Suzuki M, Kurachi T, Murata M, Kurachi M (1998) Expression of Fos protein in the limbic regions of the rat following haloperidol decanoate. Brain Res 791:125–136

  • Suzuki M, Sun YJ, Murata M, Kurachi M (1998) Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain. Psychiatry Clin Neurosci 52:353–359

  • Torres G (1994) Acute administration of alcohol blocks cocaine-induced striatal c-fos immunoreactivity protein in the rat. Synapse 18:161–167

  • Torres G, Horowitz JM, Laflamme N, Rivest S (1998) Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain. Neuroscience 87:463–477

  • Turgeon SM, Case LC (2001) The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat. Brain Res 888:302–305

  • Turgeon SM, Roche JK (1999) The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal c-Fos expression in the rat. Neuroscience 91:1265–1275

  • Umino A, Nishikawa T, Takahashi K (1995) Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem Int 26:85–90

  • Uslaner J, Badiani A, Norton CS, Day HE, Watson SJ, Akil H, Robinson TE (2001) Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13:1977–1983

  • Vahid-Ansari F, Robertson GS (1996) 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. Eur J Neurosci 8:2605–2611

  • Wan W, Ennulat DJ, Cohen BM (1995) Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res 688:95–104

  • Wang JQ, Smith AJ, McGinty JF (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68:83–95

  • Wedzony K, Czyrak A (1996) Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior cingulate cortex. J Physiol Pharmacol 47:525–533

  • Werme M, Ringholm A, Olson L, Brene S (2000) Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res 863:112–119

  • Wintrip N, Nance DM, Wilkinson M (1998) Sexually dimorphic MK801-induced c-fos in the rat hypothalamic paraventricular nucleus. Neurosci Lett 242:151–154

  • Young CD, Meltzer HY, Deutch AY (1998) Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite. Neuropsychopharmacology 19:99–103

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sumner, B.E.H., Cruise, L.A., Slattery, D.A. et al. Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs. Psychopharmacology 171, 306–321 (2004). https://doi.org/10.1007/s00213-003-1579-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1579-7

Keywords

Search

Navigation